Concepedia

Carol Knott

CK

Statistics

Publications

18

Citations

5.7K

H-Index

16

Active since

2002

Affiliations

University of Oxford(Current)

University College London

The University of Sydney

Medical Research Council

University of Otago

Carol Knott is an author at University of Oxford specializing in pharmacotherapy, chronic kidney disease, and renal disease.

Publications per year

2002–2023

18

Publications

18

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent, Martin Landray, Christina Reith et al. · The Lancet · 2011 · 2.5K citations

Pharmacy, Cardiology, Pharmacotherapy +16

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

Lixin Jiang, Jemma C. Hopewell, Jing Li et al. · European Heart Journal · 2013 · 673 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

1–5 of 18